Express Pharma

JUNE 29, 2025

This milestone marks a key development in BBL’s support for diabetes care and insulin accessibility in Malaysia. Since its entry into the Malaysian market in 2016, Biocon Biologics has supported more than 345,000 diabetes patients through the supply of rh-insulin. Biocon Biologics collaborates with Duopharma Marketing Sdn.

Diabetes 89

Diabetes Biosimilars 89

Express Pharma

JUNE 26, 2025

The approval covers vial and prefilled syringe presentations, 2 mg/0.05 A Phase 3 INSIGHT study evaluated YESAFILI against EYLEA in patients with diabetic macular oedema, with findings showing comparable pharmacokinetics, efficacy, safety, and immunogenicity. mL, and was granted on 26 June 2025.

Biosimilars 94

Biosimilars Diabetes 94

Pharmafile

APRIL 1, 2025

Rybelsus (oral semaglutide) significantly reduced the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes and cardiovascular disease (CVD) and/or chronic kidney disease (CKD).

Diabetes 59

Diabetes 59

Express Pharma

APRIL 8, 2025

Novo Nordisk has released full results from the SOUL cardiovascular outcomes trial, a phase 3b study evaluating the impact of oral semaglutide on adults with type 2 diabetes who also have cardiovascular disease (CVD) and/or chronic kidney disease (CKD). Notably, participants from the Asian region showed a 27 per cent reduction in MACE risk.

Diabetes 89

Diabetes Hospitals Labelling 89

Express Pharma

JANUARY 14, 2025

Due to their ability to effectively treat metabolic-related disorders, such as obesity and type 2 diabetes, the 11 approved GLP-1Rs generated sales of $37.2 The fact that VK-2735 may be the first oral GLP-1R to gain approval in obesity presents further commercial opportunities for Viking. billion in 2030. billion in 2030.

Diabetes 105

Diabetes 105

Express Pharma

JULY 16, 2025

Hengrui intends to present the full trial data from HRS9531-301 at an upcoming scientific conference. Participants did not have diabetes. About HRS9531 (KAI-9531) HRS9531 is a dual GLP-1/GIP receptor agonist in development as an injectable peptide for type 2 diabetes, obesity and related metabolic conditions.

Diabetes 66

Diabetes Compounding 66

Express Pharma

MARCH 2, 2025

Union Minister of State for Chemicals and Fertilisers, Anupriya Patel and Secretary, Department of Pharmaceuticals, Amit Agrawal were also present on the occasion. The target of opening 15000 JAKs by March 2025 has already been achieved by PMBI on January 31,2025.

Generic Medicine 76

Generic Medicine Diabetes 76

PharmD Live

JANUARY 8, 2025

Medicares increasing focus on quality metrics in 2025 presents critical challenges for healthcare providers. Chronic Condition Management: By providing targeted interventions for conditions like diabetes and hypertension, PCMs improve outcomes and reduce costs.

Hospitals 52

Hospitals Diabetes 52

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

Pharmacy Times

JUNE 24, 2025

What I like about this conference is it's pharmacists pulling out the abstracts, it's pharmacists presenting the abstracts, and it's a panel discussion of that abstract by pharmacists. So it's ASCO from a pharmacist perspective. And I like that. It's disease-state focused.

Pharmacy Technician 26

Pharmacy Technician Diabetes Inpatient Compounding Pharmacies 26

European Pharmaceutical Review

APRIL 18, 2025

“ ACHIEVE-1 is the first of seven Phase III studies examining the safety and efficacy of orforglipron across people with diabetes and obesity. This demonstrates promising potential for patients, as seven percent is regarded as the diabetes threshold by the American Diabetes Association’s (ADA).

Diabetes 52

Diabetes Dosage 52

Pharmacy Times

JULY 16, 2025

Hematologic malignancy presentations brought long-term evidence of benefit with Bruton tyrosine kinase (BTK) inhibitors and BCL2 combinations in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and promising early-phase results for T-cell engagers (TCEs) in myeloma and lymphoma. months; HR, 0.60; 95% CI, 0.47-0.77);

HIV Treatment and Prevention Agents 26

HIV Treatment and Prevention Agents Pharmacy Technician Diabetes Compounding Pharmacies 26

Pharmacy Times

JUNE 20, 2025

She also discusses HOPA and its partnership with Pharmacy Times in providing cutting-edge information, expressing admiration for the Oncology Pharmacist Connect (OPC) conference's rapid dissemination of relevant information and high-quality presentations. Pharmacy Times : Can you discuss your career experience as an oncology pharmacist?

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 29

Express Pharma

JANUARY 2, 2025

The type 1 diabetes (T1D) market across the seven major markets (7MM*) is set to grow at a compound annual growth rate (CAGR) of 13.3 The type 1 diabetes (T1D) market across the seven major markets (7MM*) is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in 2023 to $9.9 per cent from $2.2

Diabetes 105

Diabetes Vaccines Compounding 105

Pharmacy Times

JUNE 27, 2025

Patients often present with peripheral blood, bone marrow, and splenic involvement. 5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. There is currently no universal standard of care for MCL.

Pharmacy Technician 22

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 22

European Pharmaceutical Review

JUNE 12, 2025

Managing and integrating data from heterogeneous sources — such as genomic sequences, clinical data, biological images and chemical structures — presents a complex challenge in terms of data normalisation. Methodology for Safe and Secure AI in Diabetes Management. Internet] US Food and Drug Administration (FDA). Internet] 2024.

Drug Development 52

Drug Development Documentation Labelling Diabetes 52

Pharma Marketing Network

MARCH 5, 2025

With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. Being present at the top of search results improves brand awareness. However, the landscape isnt simple.

HIPAA 52

HIPAA Diabetes Hospitals 52

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).

Pharmacy Technician 49

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 49

Pharmacy Times

JUNE 20, 2025

1,2 A particular disease burden is present for Black Americans. However, in that month’s meeting of ACIP representatives, they voted to recommend a single dose of PCV for all adults aged 50 years and older who are PCV-naïve or who have unknown vaccination history, while keeping in place the risk-based recommendation.

Vaccines 29

Vaccines Pharmacy Technician Immunization Immunity 29

Pharmacy Times

JUNE 12, 2025

The increasing use of herbal supplements among patients undergoing cancer treatment, particularly those on oral therapies, presents a significant and often unaddressed challenge in oncology care. Participants can present their work, exchange ideas, and connect with leaders in the field during these networking opportunities.

Pharmacy Technician 45

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 45

Pharmacy Times

JUNE 25, 2025

Despite its proven efficacy, the conventional oral administration of lenalidomide presents challenges due to its short half-life and the high systemic exposure required to sustain therapeutic drug levels, which can lead to significant toxicities, particularly grade 3 or 4 hematologic adverse events (AEs).

Pharmacy Technician 20

Pharmacy Technician Immunization Immunity Diabetes 20

Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations. REFERENCES 1.

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management 29

Pharmacy Times

JULY 12, 2025

Presented at: McKesson ideaShare 2025. Find an example of someone who’s doing it somewhere else, and I’m willing to bet they’ll take the time to sit down and help you figure out how to make it work in your state.” REFERENCES 1. Kinsey JD, Meredith A, Novak N, Howard M. Nashville, TN; July 11, 2025. News release.

Pharmacy Technician 26

Pharmacy Technician Independent Pharmacies Hospitals Compounding Pharmacies 26

PharmD Live

FEBRUARY 26, 2025

Despite their efficacy, these treatments present significant challenges: Cost Barriers : High out-of-pocket expenses deter patients from starting or continuing therapy. For conditions like HIV prevention and diabetes management, non-adherence increases hospitalization risks, elevating long-term treatment costs.

Medication Therapy Management (MTM) 52

Medication Therapy Management (MTM) Hospitals Inpatient Diabetes 52

Pharmacy Times

JUNE 16, 2025

1 The findings were presented at the Revolutionizing Atopic Dermatitis (RAD) 2025 conference held in Nashville, Tennessee. The results confirm nemolizumab’s use in increasing improvements in symptoms, such as itch and skin lesions, with prolonged treatment up to 2 years.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Biosimilars Pharmacy Management 26

Pharmacy Times

JUNE 13, 2025

During an earlier presentation, Klepser states that there are 150 US counties that do not have a pharmacy or pharmacist. Presented at: American Association of Pharmacy Technicians 2025 Annual Pharmacy Technician Convention. It is absolutely crucial to know how we might get to a point where this is actually a business model. Denver, CO.

Pharmacy Technician 35

Pharmacy Technician Immunization Immunity Compounding Pharmacies 35

Pharmacy Times

JULY 19, 2025

While the results of this study were presented at the American College of Cardiology meeting in 2023, the completed study results have yet to be published. The addition of beta blockers or other drug classes are indicated when BP goals are not achieved or if concomitant comorbidities are present. Presented at ACC/WCC 2023.

HIV Treatment and Prevention Agents 22

HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies Pharmacy Management 22

Pharmacy Times

JUNE 20, 2025

In an interview with Pharmacy Times ®, Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, remote monitoring program coordinator and endocrinology clinical pharmacy specialist at the Cleveland Clinic, shares insights about the upcoming American Diabetes Association 85th Scientific Sessions.

Diabetes 32

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management 32

Pharmacy Times

JUNE 26, 2025

SHOW MORE A groundbreaking trial shows zimislecel significantly reduces insulin dependence in type 1 diabetes patients, offering hope for a functional cure. 1,2 Image credit: Davizro Photography | stock.adobe.com Zimislecel works by restoring the pancreas’ ability to produce insulin and helping individuals regulate blood sugar levels.

Diabetes 37

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management 37

Pharma Marketing Network

MARCH 5, 2025

Implement keyword-based PPC targeting for general health-related searches like “best treatment for psoriasis” or “how to manage diabetes symptoms” Optimize landing pages with lead capture forms for ongoing engagement and remarketing. Use Approved Language: Ensure medical claims are backed by clinical data.

HIPAA 52

HIPAA Diabetes 52

Drug Patent Watch

JANUARY 13, 2025

” Diabetes: Addressing a Global Epidemic With diabetes affecting millions worldwide, the advent of biosimilar insulins has been particularly impactful. Biosimilars have made significant impacts in oncology, rheumatology, and diabetes management, expanding treatment options and improving patient outcomes.

Biosimilars 61

Biosimilars Diabetes 61

Pharmacy Times

JUNE 11, 2025

Image Credit: © Chinnapong - stock.adobe.com At the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025, an encore presentation from the Pacific Coast Reproductive Society Annual Meeting will highlight findings from a retrospective analysis conducted by Walgreens Specialty Pharmacy.

Pharmacy Technician 29

Pharmacy Technician Specialty Pharmacies Compounding Pharmacies Biosimilars 29

Pharmacy Times

JUNE 17, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Participants can present their work, exchange ideas, and connect with leaders in the field during these networking opportunities. AON Pharmacy's interventions saved $1.9

Mail-Order Pharmacies 29

Mail-Order Pharmacies Pharmacy Technician Compounding Pharmacies Inpatient 29

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share what you presented at the 2025 OPC meeting? My role is really about using my expertise with medications to support decision-making based on data, like abstracts presented at meetings like this one, to ensure patients receive the best possible treatment.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Immunization Immunity 26

Pharmacy Times

JUNE 12, 2025

Biologics Versus Biosimilars Biologics Image credit: lexiconimages | stock.adobe.com Darkow begins the presentation by describing biologics as a large, complex molecule that is made of living sources, such as bacteria, yeasts, and animal cells. Unlike other medications and treatments, they are not chemically synthesized.

Biosimilars 29

Biosimilars Pharmacy Technician Immunization Immunity 29

Pharmacy Times

JUNE 23, 2025

Presented at: Hematology/Oncology Pharmacy Association 2025 Annual Conference; April 9-12, 2025; Portland, OR. If the request doesn’t come in, all 505(b)(2) drugs will be considered nontherapeutically equivalent and therefore get their own J-code. That’s the system we are headed into very rapidly.” REFERENCE Soefje SA.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Pharmacy Times

JULY 4, 2025

Patients with inflammatory conditions achieved similar clinical outcomes after switching from the reference adalimumab (Humira; AbbVie) to a biosimilar, according to real-world data presented at the 2025 American Society of Health-System Pharmacists Pharmacy Futures Meeting. 1 REFERENCES 1. Mountain J, DaCosta SS, Zuern A. (38-M) June 7–11.

Biosimilars 34

Biosimilars Specialty Pharmacies Pharmacy Technician Hospitals 34